Emcure Pharmaceuticals Q4 profit rises 29% YoY to ₹243 crore
after close1 source ↓written by the desknot a recommendation
- in net profit
- 29% YoY increase
- for Q4 FY26
- ₹243.4 crore
- last year
- ₹188.96 crore
- from operations rose
- 16.7% YoY
- ₹2,469.7 crore
Emcure Pharmaceuticals reported a 29% YoY increase in net profit to ₹243.4 crore for Q4 FY26, up from ₹188.96 crore last year. Revenue from operations rose 16.7% YoY to ₹2,469.7 crore. A dividend of ₹3.6 per share has been recommended, reflecting strong financial performance.
Not investment advice. For informational purposes only.